Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Celgene To Announce Second Quarter 2017 Results On July 27, 2017 July 4, 2017 Seattle’s PhaseRx Files for Bankruptcy as it Considers Partner, Merger or Sale Options December 10, 2017 Bay Area's Biggest Startup Factory Looks to Fund This New Type of Biotech July 4, 2017
Seattle’s PhaseRx Files for Bankruptcy as it Considers Partner, Merger or Sale Options December 10, 2017